Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Sequenom Announces Multi-Year Supply Agreement With Illumina

July 11, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, July 11, 2011 /- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company providing innovative genetic analysis solutions, today announced it has signed a three-year supply agreement with Illumina, Inc., a leading developer and manufacturer of life sciences tools for the...

PositiveID Corporation Submits FDA 510(k) Application for Its iglucose(TM) Mobile Health System for Diabetes Management

July 11, 2011 5:31 am | by PositiveID | News | Comments

PositiveID Corporation Submits FDA 510(k) Application for Its iglucose(TM) Mobile Health System for Diabetes Management

Ascribe Listed Among Top Finalists for the 2011 Microsoft Public Sector – Health Partner of the Year Award

July 11, 2011 3:33 am | by RealWire | News | Comments

Bolton, UK — July 11th, 2011 — Today, Ascribe announced it has been selected as a finalist for the Microsoft Public Sector - Health Partner of the Year Award. "Ascribe is delighted to be recognised for our continuing partnerships with NHS organisations that use our products...

Advertisement

Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions

July 11, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

BERLIN, July 11, 2011 /- John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company (NYSE: LLY ), today urged that biopharmaceuticals be included in transatlantic trade and economic discussions.  Lechleiter participated in the American Council...

Product Profiles: Systemic Lupus Erythematosus - Benlysta approval brings lessons and hope to market

July 11, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Product Profiles: Systemic Lupus Erythematosus – Benlysta approval brings lessons and hope to market...

Maximizing Pharmaceutical Licensing Opportunities

July 11, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Maximizing Pharmaceutical Licensing Opportunities...

Medicare Will Pay For MRIs When Patient Has Pacemaker

July 11, 2011 2:33 am | by Diagnostic Imaging | News | Comments

Radiologists can now charge Medicare for MRIs when the patient has a pacemarker approved for MRI exams.

FDA to Give Certain Radiological Devices a Pass

July 11, 2011 2:33 am | by Diagnostic Imaging | News | Comments

The FDA issued draft guidance July 7 to exempt 19 types of radiology device accessories from premarket notification requirements. Among the devices include film cassettes, film processors and digitizers.

Advertisement

Valeant Pharmaceuticals Agrees to Acquire Dermik

July 10, 2011 10:34 pm | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, July 11, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Valeant and its subsidiary, Valeant International (Barbados) SRL (VIB), have signed an agreement to acquire Dermik, a dermatology unit of Sanofi (EURONEXT: SAN...

Injecting Stem Cells into the Heart Could Stop Chronic Chest Pain

July 10, 2011 8:33 pm | by Massachusetts Institute of Technology | News | Comments

Early research suggests that the treatment works by promoting blood vessel growth.

GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older

July 8, 2011 9:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, July 8, 2011 /- The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 65 years of age and older for active booster immunization against tetanus,...

FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People

July 8, 2011 5:35 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 8, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO )...

Enjoy Only One Thermometer in Various Domains

July 8, 2011 10:33 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, July 8, 2011 /PRNewswire-Asia/ -- Shenzhen Wuzhou Changlian International Trading, Co., a trading company that specially wholesales series of multifunctional medical and industrial products, is pleased to announce its new round of promotion since July 1. Up to a 35%...

Advertisement

Amerigroup Foundation Presents Grant to Rx Partnership

July 8, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

VIRGINIA BEACH, Va., July 8, 2011 /- The Amerigroup Foundation recently announced that it has provided a $2,500 check to the Rx Partnership to benefit the Rockbridge Area Free Clinic. The Rx Partnership is an organization that works to provide uninsured Virginians with access to...

Stryker Announces Exclusive Collaboration With RegenLab

July 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, July 8, 2011 /- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine meeting that it has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's...

Generex Provides Preliminary Results of Generex Oral-lynâ„¢ Clinical Trials in Patients with Type 1 Diabetes and Patients with Impaired Glucose Tolerance

July 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass. and TORONTO, July 8, 2011 /- Generex Biotechnology Corporation (OTC Bulletin Board: GNBT ) ( www.generex.com ) today announced preliminary clinical results of two major trials using the Generex Oral-lyn™ formulation that will be used for registration and marketing....

TPI Schedules Test Runs at Jiangchuan Macrolide Facility by End of July

July 8, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

CHENGDU, China, July 8, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients...

Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis

July 8, 2011 1:36 am | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., July 8, 2011 /- Novartis Pharmaceuticals Corporation ("Novartis") announced today Phase III trial results that showed more than one-third of patients taking Afinitor® (everolimus) tablets* experienced a 50% or greater reduction in the size of their subependymal...

Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED

July 8, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., July 8, 2011 /- Cardiac Science Corporation , a global leader in automated external defibrillators ( AED s) and diagnostic cardiac monitoring devices, announced today that the Japan Ministry of Health, Labor, and Welfare approved a new model of its Powerheart® G3 AED....

Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazilâ„¢

July 7, 2011 9:31 am | by Bio-Medicine.Org | News | Comments

SAO PAULO and NEW BRUNSWICK, N.J., July 7, 2011 /- Johnson & Johnson (NYSE: JNJ ) today announced that the company has entered into an agreement to become a global sponsor of the 2014 FIFA World Cup Brazil™, becoming the eighth and final FIFA World Cup™ Sponsor. With this...

Detecting "Lazy Eye" Earlier

July 7, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

BOSTON, July 7, 2011 /PRNewswire-USNewswire/ -- A simple, seconds-long screening exam with a handheld scanning device may enable pediatricians to identify "lazy eye," a loss of vision in a structurally normal eye, in children as young as 2, report ophthalmologists at Children's Hospital...

Accuray's CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer

July 7, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., July 7, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced new clinical data highlighting the ability of its CyberKnife® Robotic Radiosurgery System and its TomoTherapy® Radiation Therapy System to treat a wide...

FDA Proposes New Policy for Some Diagnostic and Radiology Devices

July 7, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 7, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration issued a draft guidance today describing its intent to exercise enforcement discretion with respect to the premarket notification requirements for certain in vitro diagnostic and radiology...

Med device maker Avedro raises $25M

July 7, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ophthalmologic device and pharmaceutical developer Avedro Inc. reported today that it has raised $25 million in a Series C financing round led by SCP Vitalife and Aperture Venture Partners.

Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011

July 7, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

ANAHEIM, Calif., July 7, 2011 /- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) today announced that it will release second quarter 2011 financial results  on Tuesday, July 26, 2011 after the close of the U.S. financial markets.  The Company will host a conference call and...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading